Evidence map›Paper›PMID 37211342›Full record

Observational studyTravel medicine and infectious disease

Clinical and epidemiological characteristics of mpox: A descriptive cases series in Colombia.

Carlos A Álvarez-Moreno, Juan C Alzate-Ángel, Ilich H De La Hoz-Siegler, Adriana Bareño, Mónica Mantilla, Otto Sussman, Sandra Valderrama-Beltrán, Jose Y Rodriguez, Leonardo Arévalo, Javier Andrade-Sierra and 2 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 4 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 4 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Carlos A Álvarez-MorenoUniversidad Nacional de Colombia, Bogotá, Colombia; Clínica Colsanitas, Bogotá, Colombia. Electronic address: caalvarezmo@unal.edu.co.
Juan C Alzate-ÁngelInstituto de Evaluación Tecnológica en Salud, Bogotá, Colombia.
Ilich H De La Hoz-SieglerClínica Colsanitas, Bogotá, Colombia.
Adriana BareñoCentro Medico Teusaquillo, EPS Sanitas, Bogotá, Colombia.
Mónica MantillaVirrey Solis IPS, Bogotá, Colombia.
Otto SussmanInfectoclínicos, Bogotá, Colombia.
Sandra Valderrama-BeltránHospital Universitario San Ignacio, Pontificia Universidad Javeriana, Grupo de Investigación en Enfermedades Infecciosas, Bogotá, Colombia.
Jose Y RodriguezCentro de Investigaciones Microbiologicas del Cesar (CIMCE), Valledupar, Colombia; Secretaria Municipal de Salud, Valledupar, Colombia.
Leonardo ArévaloVirrey Solis IPS, Bogotá, Colombia.
Javier Andrade-SierraInfectoclínicos, Bogotá, Colombia.
Mónica PadillaWorld Health Organization, PanAmerican Health Organization, Bogotá, Colombia.
Ludovic ReveizKnowledge Translation Program, Evidence and Intelligence for Action in Health Department, Pan American Health Organization, Washington, DC, USA.
Asociación Colombiana de Infectología · COFundación Universitaria Sanitas · COPontificia Universidad Javeriana · COSecretaría de Salud de Bogotá · COUniversidad Nacional de Colombia · COWorld Health Organization Regional Office for the Americas · US

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionColombia is the fifth most affected country by the global monkeypox outbreak and the second in LAC after Brazil. We describe the clinical and epidemiological characteristics of 521 patients with mpox in the country.

methodsWe conducted an observational analysis of laboratory-confirmed Mpox cases between June 29 and November 16, 2022.

resultsMost cases were young men living with HIV. The clinical evolution was primarily benign, with two deaths reported. We found some differences between women and men regarding their BMI, presence of lymphadenopathies, localization of lesions, and the antecedent of HIV infection.

conclusionAlthough it seems that the epidemic curve for this outbreak of Mpox is decreasing not only in Colombia but globally, it could remain endemic. Therefore, it is necessary to maintain very close surveillance.

Indexed as

HIV InfectionsMpox, MonkeypoxBrazilColombiaDisease OutbreaksFemaleHumansMaleCommunicable diseasesDisease attributesDisease outbreaksEmergingMonkeypox

Identifiers

PMID37211342
PMCPMC10197478
OpenAlexW4377091531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.